UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Overcoming limitations in current measures of drug response may enable AI-driven precision oncology

NPJ precision oncology, 2024-04, Vol.8 (1), p.95-95, Article 95

2024

Link zum Volltext

Verfügbarkeit prüfen

ScLinear predicts protein abundance at single-cell resolution

Communications biology, 2024-03, Vol.7 (1), p.267-267, Article 267

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union

Gene, 2023-07, Vol.874, p.147481-147481, Article 147481

2023

Link zum Volltext

Verfügbarkeit prüfen

Minor intron splicing is critical for survival of lethal prostate cancer

Molecular cell, 2023-06, Vol.83 (12), p.1983-2002.e11

2023

Link zum Volltext

Verfügbarkeit prüfen

Tumour mutations in long noncoding RNAs enhance cell fitness

Nature communications, 2023-06, Vol.14 (1), p.3342-3342, Article 3342

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B008: Tumor-stromal 3D co-cultures to study the role of cancer-associated fibroblasts in the acquisition of androgen-deprivation therapy resistance in prostate cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.B008-B008

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A043: Identifying tumor heterogeneity and drug sensitivity in primary prostate cancer towards personalized medicine

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.A043-A043

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract IA014: Drug sensitivity of multifocal primary prostate cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.IA014-IA014

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract A044: Generation of a new mouse model to study the role of oncofetal Cripto in aggressive lethal prostate cancer

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.A044-A044

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract B007: New generation mTOR blocker sensitizes prostate cancer models to AR-targeting therapy

Cancer research (Chicago, Ill.), 2023-06, Vol.83 (11_Supplement), p.B007-B007

2023

Link zum Volltext

Verfügbarkeit prüfen

Matching single cells across modalities with contrastive learning and optimal transport

Briefings in bioinformatics, 2023-05, Vol.24 (3)

2023

Link zum Volltext

Verfügbarkeit prüfen

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial

BMC urology, 2023-05, Vol.23 (1), p.89-89, Article 89

2023

Link zum Volltext

Verfügbarkeit prüfen

Bladder cancer organoids as a functional system to model different disease stages and therapy response

Nature communications, 2023-04, Vol.14 (1), p.2214-2214, Article 2214

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 22: A new transgenic mouse model to explore the role of Cripto signaling in lethal prostate cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.22-22

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 182: Bladder cancer organoids as a functional system to model different disease stages and therapy response

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.182-182

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.9041-9054

2023

Link zum Volltext

Verfügbarkeit prüfen

Exploring prostate cancer in the post-genomic era

Cancer letters, 2023-01, Vol.553, p.215992-215992, Article 215992

2023

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

European urology open science (Online), 2022-10, Vol.44, p.1-10

2022

Link zum Volltext

Verfügbarkeit prüfen

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

Communications biology, 2022-07, Vol.5 (1), p.714-714, Article 714

2022

Link zum Volltext

Verfügbarkeit prüfen

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

Frontiers in toxicology, 2022-06, Vol.4, p.840606-840606

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3984: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.3984-3984

2022

Link zum Volltext

Verfügbarkeit prüfen

ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation

Cancer letters, 2022-05, Vol.534, p.215612-215612, Article 215612

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)

Publikationsform

Artikel
(105)
Tagungsberichte
(1)

Sprache

Englisch
(106)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(51)
Humans
(28)
Animals
(24)
Prostate Cancer
(22)
Male
(20)
Oncology
(20)
Tumors
(18)
Mice
(16)
Metastasis
(15)
Multidisciplinary Sciences
(13)
Science & Technology - Other Topics
(13)
Cell Biology
(10)
Cell Line, Tumor
(10)
Cell Proliferation
(9)
Gene Expression
(9)
Cancer
(8)
Organoids
(8)
Prostatic Neoplasms - Genetics
(8)
Prostatic Neoplasms - Pathology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Overcoming limitations in current measures of drug response may enable AI-driven precision oncology

ScLinear predicts protein abundance at single-cell resolution

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer

Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness

Molecular profiling of osteoprogenitor cells reveals FOS as a master regulator of bone non-union

Minor intron splicing is critical for survival of lethal prostate cancer

Tumour mutations in long noncoding RNAs enhance cell fitness

Abstract B008: Tumor-stromal 3D co-cultures to study the role of cancer-associated fibroblasts in the acquisition of androgen-deprivation therapy resistance in prostate cancer

Abstract A043: Identifying tumor heterogeneity and drug sensitivity in primary prostate cancer towards personalized medicine

Abstract IA014: Drug sensitivity of multifocal primary prostate cancer

Abstract A044: Generation of a new mouse model to study the role of oncofetal Cripto in aggressive lethal prostate cancer

Abstract B007: New generation mTOR blocker sensitizes prostate cancer models to AR-targeting therapy

Matching single cells across modalities with contrastive learning and optimal transport

Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial

Bladder cancer organoids as a functional system to model different disease stages and therapy response

Abstract 22: A new transgenic mouse model to explore the role of Cripto signaling in lethal prostate cancer

Abstract 182: Bladder cancer organoids as a functional system to model different disease stages and therapy response

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas

Exploring prostate cancer in the post-genomic era

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy

A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection

Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

Abstract 3984: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation

Aktive Filter

Suchergebnisse filtern